Slides
Page 1
Q2 FY2026-27 Result Presentation One of INDIA’S LARGEST Integrated Diagnostic Service Provider
Page 2
Disclaimer This presentation contains statements that are “forward-looking statements”, including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements pertaining to Krsnaa Diagnostics’ future business developments and economic performance. While these forward-looking statements indicate our assessment and future expectations concerning the development of our business, a number of risks, uncertainties and other unknown factors could cause actual developments and results to differ materially from our expectations. These factors include, but are not limited to, general market, macroeconomic, governmental and regulatory trends, movements in currency exchange and interest rates, competitive pressures, technological developments, changes in the financial conditions of third parties dealing with us, legislative developments, and other key factors that could affect our business and financial performance. Krsnaa Diagnostics undertakes no obligation to publicly revise any forward-looking statements to reflect future/ likely events or circumstances. © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026
Page 3
© Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 Krsnaa Diagnostics is one of the fastest growing and the largest Integrated diagnostic service provider which includes radiology, pathology and tele - radiology Provides quality care, accessibility, and accuracy at affordable rates across various segments with a focus on the Public-Private Partnership model One of India’s largest NABH-accredited tele-radiology reporting hubs with inherent capability & capacity to process X-rays, CT scans, and MRI scans, serving patients at the remotest locations in real-time. The workforce comprises 350+ radiologists, 100+ pathologists, and 3,000+ qualified professionals, including clinicians, technicians and operators 196 CT/ MRI Centres 259 Pathology Labs 8,400+ Patient Touch Points 19 States/UT Presence in India 251 Mn+ Tests in in 5 Years 334 Districts Presence PAN India 81 Million+ Patients Served In Last 5 Years 75% Centers Cover Rural Areas of India 35% YoY Retail Revenue Growth
Page 4
Company Evolution: Our Success & Scale Story A proven trajectory of PPP leadership, nationwide expansion, and diagnostic quality excellence. 200+ CT & MRI Centers 19 States Pan-India Footprint 75 NABH + 57 NABL Highest accredited centers in India PET CT Specialized Care Frontier 2011-13 INCEPTION Kick Start with 2 Radiology Centers 2013-18 PPP ENTRY 1st PPP Contract with 12 CT Centers in HP 2021-22 IPO & EXPANSION Successful IPO Listing & Expansion to 14 States 2022-23 QUALITY FIRST 1st in India to get NABH Teleradiology Accreditation 2023-24 MEGA CT /MRI PROJECTS Awarded Largest CT/MRI Projects in MH & MP. 2024-25 FOREAY IN RETAIL Retail Diagnostics Market Entry in Maharashtra, Assam, Punjab and Orissa 2025-26 PATHOLOGY MEGA PPP Awarded Largest Integrated Pathology PPP project across Rajasthan state. Strategic investment in Apulki – Oncology & Cardiac specialized diagnostics 2026-27 SPECIALIZED CARE Entry into Specialized PET CT Diagnostics in PPP
Page 5
Q2 FY27 Financial Performance 5 Particulars Q2 FY27 Q2 FY26 YoY % Revenue 2,710 2,060 32% EBIDTA 719 602 20% EBIDTA Margin 27% 29% 2% PAT 246 239 3% PAT Margin 9% 12% 3% Particulars Q2 FY27 Q2 FY26 YoY % No. of Test Performed (Mn) 30.3 16.4 85% No. of Patient Served (Mn) 7.3 5.4 35% NABL Accreditation (Pathology lab) 57 57 NABH Accreditation (Radiology Centre) 75 36 108% © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 Note: 1. Financial results of the Company are best monitored on an annual basis, as there is a certain level of cyclicity in business, and specific quarter performance may be impacted by specific events in that quarter 2. EBIDTA is excluding CSR & ESOP 3. INR in mn except NABL & NABH The moderation in margins is primarily a function of the upfront fixed cost base of Rajasthan laboratories, equipment, manpow er and logistics being carried ahead of full utilisation.
Page 6
Retail Business Highlights 6 Retail Revenue (INR Mn) 174 235 Q2 FY26 Q2 FY27 Up 35% YoY Stronger revenues driven by higher patient engagement and expanded reach Patient Count (Mn) 0.18 0.26 Q2 FY26 Q2 FY27 Up 45% YoY More patients trusting our services every day Test Volume (Mn) 0.47 0.69 Q2 FY26 Q2 FY27 Up 48% YoY Higher test volumes reflect deeper penetration and improved accessibility Revenue Per Patient (INR) 967 904 Q2 FY26 Q2 FY27 Optimizing Affordability Focused on affordability while maintaining quality and trust Retail Revenue Contribution to Group Revenue Q2 FY26 Q2 FY27 8% 9% RPL Krsnaa One Year. Multiple Milestones. Accelerating Retail Excellence. Expanding Footprint Wider reach across new geographies Deepening Patient Trust More patients. More relationships. Stronger trust. Enhancing Accessibility Better experience. Easier access. Greater convenience. Driving Sustainable Growth Stronger foundation for long-term value creation.
Page 7
Growth Drivers © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 7 1. Advanced & Specialized Testing 2. Digital Access & Home Sample Collection 3. AI & Operational Automation 1. Expanding Health Insurance Penetration 2. Increasing Test Density per Encounter 1.Unorganized-to-Organized Transition 2. Tier-2 / Tier-3 Geographical Expansion 1.Rising Burden of Chronic & Non- Communicable Diseases (NCDs) 2. Shift to Preventive & Wellness Health 3. Aging Population & Higher Life Expectancy Structural & Demographic Drivers Industry Consolidation & Organized Shift Technology & Portfolio Premiumization Ecosystem & Policy Push
Page 8
Financial Performance
Page 9
Consolidated Financial Performance © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 9 Particulars H1 FY 27 Q2 FY 26 Q2 FY 27 Q1 FY 27 H1 FY 26 In INR Mn Amount % Amount % Amount % Amount % Amount % Revenue from operations 2,710 2,060 2,355 5,065 3,990 Expenses Cost of Material Consumed 558 21% 481 23% 502 21% 1,060 21% 955 24% Employee benefits expense 367 14% 348 17% 357 15% 724 14% 698 18% Fees Channel Partners and Collection Centres 507 19% 170 8% 406 17% 913 18% 324 8% Other expenses 558 21% 459 22% 502 21% 1,061 21% 887 22% Total Expenses 1990 73% 1,458 71% 1,767 75% 3,758 74% 2,864 72% EBITDA Before CSR & ESOP 719 27% 602 29% 588 25% 1,307 26% 1,126 28% CSR and ESOP 8 0.3% 10 1% 8 0.3% 16 0.3% 20 0.5% EBITDA 711 26% 592 29% 580 25% 1,291 25% 1,106 28% Less: Finance costs 155 6% 82 4% 148 6% 303 6% 145 4% Less: Depreciation 291 11% 236 11% 280 12% 570 11% 452 11% Add: Other income 62 2% 42 2% 72 3% 134 3% 82 2% PBT 328 12% 316 15% 224 10% 552 11% 591 15% Tax 82 3% 77 4% 59 2% 141 3% 146 4% PAT 246 9% 239 12% 166 7% 411 8% 445 11%
Page 10
Consolidated Financial Performance © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 10 6 Liabilities Sep 30, 2026 Mar 31, 2026 Equity Equity share capital 162.19 162.19 Other equity 9,994.83 9,641.69 Money received against share warrants 229.37 - Total equity 10,386.39 9,803.88 Liabilities Non-current liabilities Financial liabilities Borrowings 4,027.95 4,371.44 Lease Liabilities 245.77 311.49 Other financial liabilities 789.88 666.10 Employee benefit obligations 30.39 32.01 Deferred Tax Liabilities 333.04 300.23 Other non-current liabilities - - Total non-current liabilities 5,427.03 5,681.27 Current liabilities Financial liabilities Borrowings 1,565.46 533.61 Lease Liabilities 125.14 126.63 Trade payables 2,317.41 632.02 Other financial liabilities 506.39 1,251.23 Other current liabilities 64.43 90.96 Provision 101.41 86.07 Current Tax Liabilities (net) 142.18 31.49 Current liabilities 4,822.42 2,752.01 Total Liabilities 10,249.45 8,433.28 Total Equity and Liabilities 20,635.84 18,237.16 Assets Sep 30, 2026 Mar 31, 2026 Non-current assets Property, plant and equipment 8,488.28 6,516.27 Capital work-in-progress 52.02 2,080.72 Intangible assets 215.09 48.41 Financial assets Investments 574.28 574.28 Other financial assets 1,157.48 358.74 Deferred tax asset (net) 60.58 50.44 Other non-current assets 2,436.03 1,224.90 Total non-current assets 12,983.76 10,853.76 Current assets Inventories 333.04 266.57 Financial assets Trade receivables 4,745.56 2,955.06 Cash and cash equivalents 774.01 302.22 Bank balances other than cash and cash equivalent 1,142.17 3,304.95 Other financial assets 223.87 313.20 Other current assets 433.43 241.40 Total current assets 7,652.08 7,383.40 Total Assets 20,635.84 18,237.16 (INR In Mn)
Page 11
Patient Experience at Its Best
Page 12
Growth Engine- Enabling Reliable Diagnostics © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 12 Actual centre images Gargoti , Maharashtra Varanasi , Uttar Pradesh Ahhilya Nagar , Maharashtra
Page 13
© Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 13 Conferences and meetings with Doctors Activities in Retail Business Doctor Engagement Activities
Page 14
Activities in Retail Business © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 14 Independence Day Camps across region
Page 15
Activities in Digital Marketing © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 15 Social Media Awareness Campaigns
Page 16
Contact Information This presentation contains statements that are “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Krsnaa Diagnostics’ future business developments and economic performance. While these forward-looking statements indicate our assessment and future expectations concerning the development of our business, a number of risks, uncertainties and other unknown factors could cause actual developments and results to differ materially from our expectations. These factors include, but are not limited to, general market, macro-economic, governmental and regulatory trends, movements in currency exchange and interest rates, competitive pressures, technological developments, changes in the financial conditions of third parties dealing with us, legislative developments, and other key factors that could affect our business and financial performance. Krsnaa Diagnostics undertakes no obligation to publicly revise any forward-looking statements to reflect future / likely events or circumstances. © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 Krsnaa Diagnostics Sujoy Bose, Head- Secretarial, Legal and Compliance investors@krsnaa.in Contact: +91 73910 40109 For further information please contact
Page 17
Krsnaa Diagnostics Sujoy Bose, Head- Secretarial, Legal and Compliance investors@krsnaa.in Contact: +91 73910 40109 https://krsnaadiagnostics.com For further information please contact